AzTrials
AzTrials

Post-Traumatic Stress Disorder ComplexNCT07040462

Child-Parent Psychotherapy After the 2023 Kahramanmaraş Earthquake

A study testing Child-Parent Psychotherapy (CPP) in people with Post-Traumatic Stress Disorder Complex and Emotional Dysregulation, run by Beykoz University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of Child-Parent Psychotherapy (CPP) in reducing trauma-related symptoms and improving attachment quality among preschool-aged children who experienced the 2023 Kahramanmaraş earthquakes in Türkiye. Read more about this study

Who is it for?
Ages 3 to 65 yearsHealthy volunteers can take part
What is being tested?
Child-Parent Psychotherapy (CPP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jun 2025to 15 Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Children aged 3 to 6 years old at the time of enrollment
  • Resided in one of the 11 cities affected by the 2023 Kahramanmaraş earthquake (e.g., Hatay, Kahramanmaraş, Adıyaman, Malatya, Gaziantep, Şanlıurfa, Adana, Osmaniye, Diyarbakır, Kilis, Elazığ)
  • Exposure to at least one qualifying traumatic event due to the earthquake (e.g., witnessing injury or death, loss of home, separation from caregiver)
  • Living with a primary caregiver (mother or father) who consents to participate in the study
  • Both caregiver and child are available to participate in 12 weekly sessions of CPP (online or face-to-face)
  • Caregiver is fluent in Turkish and able to complete self-report questionnaires

Who cannot join

  • Child or caregiver currently receiving psychotherapy or psychiatric treatment
  • Child diagnosed with developmental disorder (e.g., autism, intellectual disability) that significantly impairs communication or relational functioning
  • Caregiver with a diagnosed severe psychiatric disorder (e.g., psychosis, bipolar disorder) or active substance use disorder
  • Families with ongoing legal custody disputes or instability that may interfere with consistent participation
  • Inability to access internet or digital device (for participants randomized to online therapy)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eda Yılmazer, Phd contact

+905322575880

edayilmazer@beykoz.edu.tr

Metin Çınaroğlu, Phd contact

+9053247320

metincinaroglu@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Beykoz University

    Istanbul, Istanbul, 34340

    Eda Yılmazer, Phd, +905322575880, edayilmazer@beykoz.edu.tr

    Metin Çınaroğlu, Phd, 09053247320, metincinaroglu@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Child-Parent Psychotherapy for Post-Earthquake Trauma in Preschool Children: A Randomized Controlled Trial

This study aims to evaluate the effectiveness of Child-Parent Psychotherapy (CPP) in reducing trauma-related symptoms and improving attachment quality among preschool-aged children who experienced the 2023 Kahramanmaraş earthquakes in Türkiye. A total of 60 caregiver-child dyads (children aged 3-6) will be recruited from 11 earthquake-affected provinces. Participants will be randomly assigned to either the intervention group, receiving 12 weekly CPP sessions, or a no-intervention control group. CPP will be delivered by trained clinical psychologists through either online or face-to-face sessions. Assessments will be conducted at baseline, mid-intervention (after session 6), and post-intervention (after session 12). Outcomes include child trauma symptoms, social-emotional functioning, and attachment quality, as well as caregiver reflective functioning, stress, and emotional well-being.

Read the detailed description

This randomized controlled trial investigates the impact of Child-Parent Psychotherapy (CPP) on post-traumatic recovery and attachment in children aged 3 to 6 years who were exposed to the 2023 Kahramanmaraş earthquakes. CPP is a trauma-informed dyadic therapy that integrates psychodynamic, cognitive-behavioral, attachment, and developmental principles, emphasizing co-construction of trauma narratives and caregiver reflective functioning through play-based interaction.

The study will enroll 60 caregiver-child dyads from the 11 most affected cities in Türkiye: Kahramanmaraş, Hatay, Adıyaman, Gaziantep, Malatya, Adana, Osmaniye, Diyarbakır, Şanlıurfa, Kilis, and Elazığ. Eligible participants include children who were between 1-4 years old at the time of the disaster and are currently aged 3-6, along with a primary caregiver (mother or father) who is consistently involved in daily care.

The intervention group will receive 12 weekly CPP sessions (60 minutes each), conducted either online or in person, depending on logistical and contextual needs. Sessions will be delivered by licensed clinical psychologists trained in the CPP protocol. The control group will receive no intervention during the trial period but will complete assessments in parallel with the intervention group.

Primary outcomes include reduction in child trauma symptoms and improvement in social-emotional functioning and attachment quality. Secondary outcomes include parental stress, reflective functioning, and symptoms of depression, anxiety, and stress. Data will be collected at three timepoints: baseline (T1), mid-intervention (after session 6, T2), and post-intervention (after session 12, T3).

All instruments are validated in Turkish populations and age-appropriate. The child measures include the Ages \& Stages Questionnaires: Social-Emotional (ASQ:SE), Brief Attachment Scale (BAS-16), and a trauma symptom checklist appropriate for preschoolers. Caregiver measures include the Parental Reflective Functioning Questionnaire (PRFQ), Parenting Stress Index Short Form (PSI-SF), and the Depression Anxiety Stress Scale (DASS-21).

Being tested
Child-Parent Psychotherapy (CPP)
Keywords
Child-Parent Psychotherapy (CPP), Trauma Therapy, Preschool Children, Kahramanmaraş Earthquake

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Child-Parent Psychotherapy (CPP)Behavioural

    CPP is a structured, evidence-based dyadic therapy designed for children aged 0-6 exposed to trauma and their caregivers. The intervention involves weekly joint sessions emphasizing safety, emotional expression, and caregiver reflective functioning. Delivered by trained psychologists either online or in person.

Study groups in NCT07040462
Study groupRoleWhat they receive
Child-Parent Psychotherapy (CPP)ExperimentalParticipants in this arm will receive 12 weekly Child-Parent Psychotherapy (CPP) sessions, each lasting approximately 60 minutes. CPP is a trauma-informed, attachment-based intervention that integrates psychodynamic, cognitive-behavioral, and developmental principles. Sessions are dyadic (child and caregiver together) and may be conducted face-to-face or online. Therapists are trained clinical psychologists. The intervention focuses on emotional regulation, trauma narrative development, and strengthening the caregiver-child bond.
Receives: Behavioral: Child-Parent Psychotherapy (CPP)
No-Treatment ControlNo interventionParticipants in this arm will receive no psychological intervention during the 12-week study period. They will, however, complete outcome assessments at the same three timepoints as the intervention group (baseline, mid-intervention, and post-intervention).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Child Trauma Symptom Severity

    Child trauma symptoms will be assessed using the Child PTSD Reaction Index (CPTSD-RI), a 20-item caregiver-report scale developed to evaluate post-traumatic stress reactions in children following exposure to traumatic events. Items are rated on a 5-point Likert scale ranging from 0 (none) to 4 (most of the time), yielding a total score ranging from 0 to 80. Higher scores reflect greater severity of PTSD symptoms, with cutoffs indicating doubtful (0-11), mild (12-24), moderate (25-39), severe (40-59), and very severe (60-80) symptom levels. The measure will be administered at three time points: baseline (Week 0), mid-treatment (Week 6), and post-treatment (Week 12).

    Measured: From baseline (Week 0) to 12 weeks post-intervention.

Secondary outcomes (5)
  1. Change in Child Social-Emotional Functioning

    Assessed using the ASQ:SE, a caregiver-report scale evaluating emotion regulation, social interaction, and adaptive functioning. Total scores vary by age version, typically up to ~310. Higher scores indicate more social-emotional difficulties.

    Measured: From baseline (Week 0) to 12 weeks post-intervention.

  2. Change in Child Attachment Security

    Measured using the BAS-16, a 16-item scale assessing attachment security and proximity-seeking. Scores range from 16 to 80, with higher scores indicating more secure attachment.

    Measured: From baseline (Week 0) to 12 weeks post-intervention.

  3. Change in Parental Reflective Functioning

    Evaluated using the PRFQ, an 18-item caregiver-report measure of mentalization. Scores range from 18 to 126, with interpretation based on subscale balance.

    Measured: From baseline (Week 0) to 12 weeks post-intervention.

  4. Change in Parenting Stress

    Measured by the PSI-SF, a 36-item scale with scores ranging from 36 to 180, where higher scores indicate greater stress.

    Measured: From baseline (Week 0) to 12 weeks post-intervention

  5. Change in Caregiver Depression, Anxiety, and Stress

    Assessed by the DASS-21, which yields three subscale scores (each 0-42) for depression, anxiety, and stress. Higher scores indicate greater emotional distress.

    Measured: From baseline (Week 0) to 12 weeks post-intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2025
  2. Study start15 Jun 2025
  3. Primary completion15 Oct 2025 (estimated)
  4. Study completion15 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of two parallel arms: (1) Child-Parent Psychotherapy (CPP) or (2) No-treatment control. Each participant remains in their assigned arm throughout the 12-week study.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07040462
Sponsor's protocol ID
CPP-Kahramanmaras-RCT-2025
Status last verified
Jun 2025
First submitted
18 Jun 2025
Last updated
27 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data (IPD) that underlie the results reported in this study (after de-identification) will be made available to researchers who provide a methodologically sound proposal. Data will include participant-level data for primary and secondary outcomes. Supporting documents such as the study protocol, statistical analysis plan, and informed consent form will also be made available upon request. Data will be available beginning 6 months after publication of the main findings and will remain accessible for 3 years via a secure institutional repository or upon request to the principal investigator.

Questions about this trial

What is this clinical trial studying?

A study testing Child-Parent Psychotherapy (CPP) in people with Post-Traumatic Stress Disorder Complex and Emotional Dysregulation, run by Beykoz University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eda Yılmazer, Phd (+905322575880, edayilmazer@beykoz.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Child Trauma Symptom Severity (time frame: From baseline (Week 0) to 12 weeks post-intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in